How big pharma could lose the war on disease
Bloomberg - 12/02/2015
Biologist Kim Lewis of Northeastern University, who has studied antibiotic development, sees the primary problem as the lack of any method for finding promising compounds. All the amazing progress a half century ago came when U.S. biochemist Selman Waksman developed a technique to systematically screen soil bacteria. This is how he discovered streptomycin, the first treatment for tuberculosis. After turning up other valuable drugs such as tetracycline, erythromycin and vancomycin, the technique eventually petered out. We still have nothing to replace it.